182 related articles for article (PubMed ID: 9392299)
1. Characterization of pigs transgenic for human decay-accelerating factor.
Cozzi E; Tucker AW; Langford GA; Pino-Chavez G; Wright L; O'Connell MJ; Young VJ; Lancaster R; McLaughlin M; Hunt K; Bordin MC; White DJ
Transplantation; 1997 Nov; 64(10):1383-92. PubMed ID: 9392299
[TBL] [Abstract][Full Text] [Related]
2. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs.
Bennet W; Björkland A; Sundberg B; Brandhorst D; Brendel MD; Richards A; White DJ; Nilsson B; Groth CG; Korsgren O
Transplantation; 2001 Jul; 72(2):312-9. PubMed ID: 11477359
[TBL] [Abstract][Full Text] [Related]
3. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days.
Ramirez P; Chavez R; Majado M; Munitiz V; Muñoz A; Hernandez Q; Palenciano CG; Pino-Chavez G; Loba M; Minguela A; Yelamos J; Gago MR; Vizcaino AS; Asensi H; Cayuela MG; Segura B; Marin F; Rubio A; Fuente T; Robles R; Bueno FS; Sansano T; Acosta F; Rodriguez JM; Navarro F; Cabezuelo J; Cozzi E; White DJ; Calne RY; Parrilla P
Transplantation; 2000 Oct; 70(7):989-98. PubMed ID: 11045632
[TBL] [Abstract][Full Text] [Related]
4. Transgenic pigs expressing human decay-accelerating factor regulated by porcine MCP gene promoter.
Murakami H; Nagashima H; Takahagi Y; Miyagawa S; Fujimura T; Toyomura K; Nakai R; Yamada M; Kurihara T; Shigehisa T; Okabe M; Seya T; Shirakura R; Kinoshita T
Mol Reprod Dev; 2002 Mar; 61(3):302-11. PubMed ID: 11835575
[TBL] [Abstract][Full Text] [Related]
5. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
[TBL] [Abstract][Full Text] [Related]
6. The influence of baseline expression of human decay accelerating factor transgene on graft survival and acute humoral xenograft rejection.
Sun H; Chen G; Liu W; Kubelik D; Yang H; White DJ; Zhong R; Garcia B
Transplantation; 2005 Nov; 80(9):1331-9. PubMed ID: 16314803
[TBL] [Abstract][Full Text] [Related]
7. Production and characterization of a pig line transgenic for human membrane cofactor protein.
Zhou CY; McInnes E; Parsons N; Langford G; Lancaster R; Richards A; Pino-Chavez G; Dos Santos Cruz G; Copeman L; Carrington C; Thompson S
Xenotransplantation; 2002 May; 9(3):183-90. PubMed ID: 11983016
[TBL] [Abstract][Full Text] [Related]
8. Transgenic pigs expressing human CD59, in combination with human membrane cofactor protein and human decay-accelerating factor.
Zhou CY; McInnes E; Copeman L; Langford G; Parsons N; Lancaster R; Richards A; Carrington C; Thompson S
Xenotransplantation; 2005 Mar; 12(2):142-8. PubMed ID: 15693845
[TBL] [Abstract][Full Text] [Related]
9. Successful cross-breeding of cloned pigs expressing endo-beta-galactosidase C and human decay accelerating factor.
Yazaki S; Iwamoto M; Onishi A; Miwa Y; Suzuki S; Fuchimoto D; Sembon S; Furusawa T; Hashimoto M; Oishi T; Liu D; Nagasaka T; Kuzuya T; Maruyama S; Ogawa H; Kadomatsu K; Uchida K; Nakao A; Kobayashi T
Xenotransplantation; 2009; 16(6):511-21. PubMed ID: 20042051
[TBL] [Abstract][Full Text] [Related]
10. Immunopathological observations after xenogeneic liver perfusions using donor pigs transgenic for human decay-accelerating factor.
Pascher A; Poehlein C; Storck M; Prestel R; Mueller-Hoecker J; White DJ; Abendroth D; Hammer C
Transplantation; 1997 Aug; 64(3):384-91. PubMed ID: 9275100
[TBL] [Abstract][Full Text] [Related]
11. Transgenic expression in pig hearts of both human decay-accelerating factor and human membrane cofactor protein does not provide an additional benefit to that of human decay-accelerating factor alone in pig-to-baboon xenotransplantation.
Mañez R; Lopez-Pelaez E; Centeno A; Herrera JM; Juffe A; Domenech N; Harrison R; Schuurman HJ
Transplantation; 2004 Sep; 78(6):930-3. PubMed ID: 15385816
[TBL] [Abstract][Full Text] [Related]
12. Protection of hDAF-transgenic porcine endothelial cells against activation by human complement: role of the membrane attack complex.
Fecke W; Long J; Richards A; Harrison R
Xenotransplantation; 2002 Mar; 9(2):97-105. PubMed ID: 11897002
[TBL] [Abstract][Full Text] [Related]
13. Hyperacute lung rejection in the pig-to-human model. 2. Synergy between soluble and membrane complement inhibition.
Azimzadeh A; Zorn GL; Blair KS; Zhang JP; Pfeiffer S; Harrison RA; Cozzi E; White DJ; Pierson RN
Xenotransplantation; 2003 Mar; 10(2):120-31. PubMed ID: 12588645
[TBL] [Abstract][Full Text] [Related]
14. Efficient production by sperm-mediated gene transfer of human decay accelerating factor (hDAF) transgenic pigs for xenotransplantation.
Lavitrano M; Bacci ML; Forni M; Lazzereschi D; Di Stefano C; Fioretti D; Giancotti P; Marfé G; Pucci L; Renzi L; Wang H; Stoppacciaro A; Stassi G; Sargiacomo M; Sinibaldi P; Turchi V; Giovannoni R; Della Casa G; Seren E; Rossi G
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14230-5. PubMed ID: 12393815
[TBL] [Abstract][Full Text] [Related]
15. Effect of cell surface concentration of human DAF on transgenic pig aortic endothelial cells on the degree of protection afforded against human complement deposition.
Carrington CA; dos Santos Cruz G
Xenotransplantation; 2001 May; 8(2):100-5. PubMed ID: 11328580
[TBL] [Abstract][Full Text] [Related]
16. HDAF transgenic pig livers are protected from hyperacute rejection during ex vivo perfusion with human blood.
Luo Y; Levy G; Ding J; Qi J; Chakbrati S; Garcia BM; Phillips MJ; Kumar N; Friend P; Noble L; Macdonald J; Zhong R; Grant D
Xenotransplantation; 2002 Jan; 9(1):36-44. PubMed ID: 12005103
[TBL] [Abstract][Full Text] [Related]
17. Analysis of transgene integration sites in transgenic pigs by fluorescence in situ hybridization.
Kuipers HW; Langford GA; White DJ
Transgenic Res; 1997 Jul; 6(4):253-9. PubMed ID: 9232026
[TBL] [Abstract][Full Text] [Related]
18. The in vitro protection of human decay accelerating factor and hDAF/heme oxygenase-1 transgenes in porcine aortic endothelial cells against sera of Formosan macaques.
Tu CF; Tai HC; Wu CP; Ho LL; Lin YJ; Hwang CS; Yang TS; Lee JM; Tseng YL; Huang CC; Weng CN; Lee PH
Transplant Proc; 2010; 42(6):2138-41. PubMed ID: 20692427
[TBL] [Abstract][Full Text] [Related]
19. Potential value of human thrombomodulin and DAF expression for coagulation control in pig-to-human xenotransplantation.
Miwa Y; Yamamoto K; Onishi A; Iwamoto M; Yazaki S; Haneda M; Iwasaki K; Liu D; Ogawa H; Nagasaka T; Uchida K; Nakao A; Kadomatsu K; Kobayashi T
Xenotransplantation; 2010; 17(1):26-37. PubMed ID: 20149186
[TBL] [Abstract][Full Text] [Related]
20. Relation between human decay-accelerating factor (hDAF) expression in pig cells and inhibition of human serum anti-pig cytotoxicity: value of highly expressed hDAF for xenotransplantation.
Liu D; Kobayashi T; Onishi A; Furusawa T; Iwamoto M; Suzuki S; Miwa Y; Nagasaka T; Maruyama S; Kadomatsu K; Uchida K; Nakao A
Xenotransplantation; 2007 Jan; 14(1):67-73. PubMed ID: 17214706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
